Osteoporosis, Postmenopausal clinical trials at UC Health
1 research study open to eligible people
Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid
open to eligible females ages 50 years and up
This study evaluates how patients treated with denosumab or zoledronic acid for osteoporosis may change the number of peripheral osteoclast precursors and osteoclast activity, and how that may be associated with changes in bone mass.
at UC Davis